Camel

General Information


DRACP ID  DRACP00231

Peptide Name   Camel

Sequence  KWKLFKKIGAVLKVL

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Ceropin-Melittin hybrid

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10 Mouse melanoma Carcinoma LC50=1.75 µM MTT assay 24 h 1
RenCa Mouse kidney carcinoma Carcinoma LC50=1.3 µM MTT assay 24 h 1
4T1 Malignant neoplasms of the mouse mammary gland Carcinoma LC50=6.2 µM MTT assay 24 h 1
WM1158 Melanoma Carcinoma LC50=4.1 µM MTT assay 24 h 1

Hemolytic Activity  At CAMEL concentrations toxic for B16-F10 cells the peptide did not cause erythrocyte hemolysis.

Normal (non-cancerous) Cytotoxicity  Increasing the amount of CAMEL (1–20 μM) proved toxic to all tested cell lines The LC50 values were from 2.95 to 5.2 μM for normal cells (HECa10, HEC PP, NIH3T3, Wi38)

Target  Not available

Affinity  Not available

Mechanism  specific combinations of necrosis-inducing peptide (CAMEL) and IL-12-carrying plasmid DNA can inhibit tumor growth as well as prevent tumor relapse

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  2JMY 

Predicted Structure  DRACP00231

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H151N21O16

Absent amino acids  CDEHMNPQRSTY

Common amino acids  K

Mass  202122

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  9

Net charge  5

Boman Index  807

Hydrophobicity  54

Aliphatic Index  149.33

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  392.86

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20212453

Title  Anticancer effects of CAMEL peptide

Doi 10.1038/labinvest.2010.58

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.